“…While pregabalin was not shown to be effective in this clinical instance, we applaud The Journal and study authors for publishing results from a “negative trial.” Publication bias is a major issue within the urological literature, with some journals publishing negative results in only 3% of reported trials. 5 Without publication of these studies our knowledge becomes skewed. A recent editorial commentary by DeVito and Goldacre acknowledged this and called on the scientific community to improve.…”